Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models
Lily L. Nguyen(University of Colorado Boulder), Benjamin G. Bitler(University of Colorado Denver)
Cited by 1
Related Papers
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
|Oncogenesis|2018|86
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma
|Molecular Cancer Therapeutics|2022|21
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression
|Cancer Research Communications|2024|21
Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors
|Molecular Cancer Therapeutics|2022|17
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
|Molecular Cancer Therapeutics|2024|11